These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7726275)

  • 21. How frequently should a patient taking amiodarone be screened for thyroid dysfunction?
    Pazin-Filho A; de Jesus AM; Magalhães PK; Melato LH; Campos D; Maciel BC; Maciel LM
    Braz J Med Biol Res; 2009 Aug; 42(8):744-9. PubMed ID: 19649401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone and the thyroid gland].
    Stäubli M; Bischof P; Wimpfheimer C; Studer H
    Schweiz Med Wochenschr; 1981 Oct; 111(43):1590-6. PubMed ID: 7302543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
    Capone CA; Gebb J; Dar P; Shenoy RU
    J Neonatal Perinatal Med; 2014; 7(4):305-9. PubMed ID: 25468615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease.
    Tanaka K; Tanaka H; Kamiya C; Katsuragi S; Sawada M; Tsuritani M; Yoshida M; Iwanaga N; Yoshimatsu J; Ikeda T
    Circ J; 2016 Sep; 80(10):2221-6. PubMed ID: 27593227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of delivery and neonatal outcomes for small-for-gestational-age fetuses.
    Visentin S; Londero AP; Grumolato F; Trevisanuto D; Zanardo V; Ambrosini G; Cosmi E
    J Ultrasound Med; 2014 Oct; 33(10):1721-8. PubMed ID: 25253817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone-induced thyroid dysfunction associated with cumulative dose.
    Bouvy ML; Heerdink ER; Hoes AW; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2002; 11(7):601-6. PubMed ID: 12462138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neonatal outcome after exposure to beta adrenergic blockers late in pregnancy].
    Cissoko H; Jonville-Béra AP; Swortfiguer D; Giraudeau B; Autret-Leca E
    Arch Pediatr; 2005 May; 12(5):543-7. PubMed ID: 15885543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of cardiac arrhythmias during pregnancy: safety considerations.
    Joglar JA; Page RL
    Drug Saf; 1999 Jan; 20(1):85-94. PubMed ID: 9935279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal treatment of fetal hypothyroidism: is there more than one option?
    Nicolini U; Venegoni E; Acaia B; Cortelazzi D; Beck-Peccoz P
    Prenat Diagn; 1996 May; 16(5):443-8. PubMed ID: 8844003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone-induced thyroid dysfunction.
    Khanderia U; Jaffe CA; Theisen V
    Clin Pharm; 1993 Oct; 12(10):774-9. PubMed ID: 8258259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    BJOG; 2014 Aug; 121(9):1090-6. PubMed ID: 24628701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of amiodarone during pregnancy.
    Robson DJ; Jeeva Raj MV; Storey GC; Holt DW
    Postgrad Med J; 1985 Jan; 61(711):75-7. PubMed ID: 3991412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of amiodarone therapy on thyroid iodine content as measured by x-ray fluorescence.
    Fragu P; Schlumberger M; Davy JM; Slama M; Berdeaux A
    J Clin Endocrinol Metab; 1988 Apr; 66(4):762-9. PubMed ID: 3346355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery--correlation with short-term outcome.
    Schwarze A; Gembruch U; Krapp M; Katalinic A; Germer U; Axt-Fliedner R
    Ultrasound Obstet Gynecol; 2005 Jun; 25(6):573-9. PubMed ID: 15912468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.
    Smith LM; LaGasse LL; Derauf C; Grant P; Shah R; Arria A; Huestis M; Haning W; Strauss A; Della Grotta S; Liu J; Lester BM
    Pediatrics; 2006 Sep; 118(3):1149-56. PubMed ID: 16951010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction.
    Yamato M; Wada K; Fujimoto M; Hosomi K; Hayashi T; Oita A; Takada M
    Eur J Clin Pharmacol; 2017 Mar; 73(3):289-296. PubMed ID: 28083650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First trimester thyroid stimulating hormone as an independent risk factor for adverse pregnancy outcome.
    Arbib N; Hadar E; Sneh-Arbib O; Chen R; Wiznitzer A; Gabbay-Benziv R
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2174-2178. PubMed ID: 27677438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone therapy during pregnancy.
    McKenna WJ; Harris L; Rowland E; Whitelaw A; Storey G; Holt D
    Am J Cardiol; 1983 Apr; 51(7):1231-3. PubMed ID: 6837469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.